ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

ClinicalTrials.gov ID: NCT00089570

Public ClinicalTrials.gov record NCT00089570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 5:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III Study of Intravenous Terlipressin in Patients With Hepatorenal Syndrome Type 1

Study identification

NCT ID
NCT00089570
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mallinckrodt
Industry
Enrollment
112 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • terlipressin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Feb 28, 2006
Completion
Aug 31, 2006
Last update posted
Oct 26, 2017

2004 – 2006

United States locations

U.S. sites
37
U.S. states
25
U.S. cities
32
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054
University of Arizona College of Medicine Tucson Arizona 85724-5136
UCLA School of Medicine Los Angeles California 90095
UC Davis Medical Center Sacramento California 95817
UCSD Medical Center Hillcrest San Diego California 92103-9707
VA Medical Center San Diego California 92161
California Pacific Medical Center San Francisco California 94115
University of California, San Francisco San Francisco California 94143-0538
University of Colorado Hospital & Health Sciences Center Denver Colorado 80262
Yale New Haven Hospital New Haven Connecticut 06520-8019
VA CT Health Care System West Haven Connecticut 06516
Georgetown University Hospital Washington D.C. District of Columbia 20007
Mayo Clinic Jacksonville Jacksonville Florida 32224
Northwestern Memorial Hospital Chicago Illinois 60611
Tulane University Health Sciences Center New Orleans Louisiana 70112
The Johns Hopkins Hospital Baltimore Maryland 21205
Lahey Clinic Burlington Massachusetts 01805
Henry Ford Hospital Detroit Michigan 48202
Fairview-University Medical Center Minneapolis Minnesota 55455
Mayo Clinic Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
983285 Nebraska Medical Center Omaha Nebraska 68198-3285
University of Medicine & Dentistry of New Jersey - NJMS Newark New Jersey 07101-1709
Weill Cornell Medical Center New York New York 10021
Mount Sinai Medical Center/Mount Sinai Hospital New York New York 10029
Center for Liver Disease & Transplantation Clinic New York New York 10032
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7080
Cleveland Clinic Foundation Cleveland Ohio 44195
Oregon Health Sciences University Portland Oregon 97239-3098
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
Medical University of South Carolina Charleston South Carolina 29425
Methodist University Hospital Memphis Tennessee 38103
University of Texas Southwestern Medical Center of Dallas Dallas Texas 75390-9151
St. Luke's Episcopal Hospital, St. Luke's Texas Liver Institute Houston Texas 77030
VCU Medical Center Richmond Virginia 23298
University of Washington Medical Center Seattle Washington 98195-6174

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00089570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2017 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00089570 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →